Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

7.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.9K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.4K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.4K
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

8
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
8
Bone Remodeling01:40

Bone Remodeling

34.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.3K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

3.2K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.2K
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

4
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
4

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Best practice & research clinical endocrinology & metabolism prolactinoma.

Best practice & research. Clinical endocrinology & metabolism·2026
Same author

Consensus on acromegaly complications: an update.

Pituitary·2026
Same author

Current treatment landscape of acromegaly.

The Journal of clinical endocrinology and metabolism·2026
Same author

The cross-talk between prolactin and growth hormone in pituitary adenomas.

Best practice & research. Clinical endocrinology & metabolism·2026
Same author

Approach to the Patient With Traumatic Brain Injury-induced Pituitary Dysfunction.

The Journal of clinical endocrinology and metabolism·2026
Same author

Consensus on acromegaly therapeutic outcomes: an update.

Nature reviews. Endocrinology·2025
Same journal

EDITORIAL INTRODUCTION.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Exploring the role of parathyroid hormone in sarcopenia: A review.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Prediabetes before pregnancy: implications for risk stratification and research.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence.

Current opinion in endocrinology, diabetes, and obesity·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

87.6K

Acromegaly and bone disease.

Jeremy R Anthony1, Adriana G Ioachimescu

  • 1aDivision of Endocrinology, Department of Internal Medicine bDepartment of Neurosurgery, Emory University, Atlanta, Georgia, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity
|October 30, 2014
PubMed
Summary
This summary is machine-generated.

Patients with acromegaly face a higher risk of vertebral fractures, even after treatment. Managing acromegaly activity, hypogonadism, and other osteoporosis risk factors is crucial for bone health.

More Related Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

13.2K

Related Experiment Videos

Last Updated: Apr 21, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

87.6K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

13.2K

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Osteoporosis Research

Background:

  • Acromegaly, a condition of excess growth hormone, significantly impacts bone health.
  • Understanding the specific skeletal complications, particularly osteoporosis, is vital for patient management.

Purpose of the Study:

  • To review and update the current understanding of osteoporosis in patients with acromegaly.
  • To highlight the risks and contributing factors for fractures in this population.

Main Methods:

  • Review of current literature on acromegaly and bone metabolism.
  • Analysis of fracture risk, bone mineral density, and bone turnover markers in acromegaly patients.

Main Results:

  • Acromegaly patients exhibit an increased risk of morphometric vertebral fractures, persisting even after biochemical control.
  • Bone mineral density may be normal, increased, or decreased and often discordant with fracture occurrence.
  • Coexisting conditions like hypogonadism and diabetes mellitus exacerbate osteoporosis risk.

Conclusions:

  • Screening for vertebral fractures using radiographs is recommended for all acromegaly patients.
  • Biochemical control of acromegaly, addressing hypogonadism, and avoiding excessive glucocorticoids are key management strategies.
  • Further research is needed to elucidate the mechanisms of skeletal fragility and optimize treatment for acromegaly-associated osteoporosis.